- Home
- DGICB vs PACB Comparison
DGICB vs PACB Comparison
Compare DGICB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICB | PACB |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.6M | 419.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | DGICB | PACB |
|---|---|---|
| Price | $17.51 | $1.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.83 |
| AVG Volume (30 Days) | 2.6K | ★ 5.4M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $2.26 | $11.32 |
| Revenue Next Year | N/A | $12.13 |
| P/E Ratio | $8.06 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $13.84 | $0.85 |
| 52 Week High | $20.30 | $2.73 |
Technical Indicators
Market Signals| Indicator | DGICB | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 62.36 | 52.13 |
| Support Level | $15.57 | $1.20 |
| Resistance Level | $19.99 | $1.51 |
| Average True Range (ATR) | 0.63 | 0.09 |
| MACD | 0.28 | 0.03 |
| Stochastic Oscillator | 97.68 | 63.89 |
Price Performance
Historical ComparisonAbout DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.